Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | KMO | O15229 | 1/20 | 0.44 |
| ▸ | CRHBP | P24387 | 1/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL242170 | 0.87 | KMO (0.56) | KMT2AMAPTCYP1A2CYP2D6MEN1 | |
| SCHEMBL244072 | 0.85 | PIK3CA (0.47) | KMT2AMAPTCYP1A2CYP2D6MEN1 | |
| SCHEMBL241043 | 0.85 | PIK3CB (0.57) | KMT2AMAPTCYP1A2CYP2D6MEN1 | |
| SCHEMBL29434078 | 0.85 | PIK3CA (0.47) | KMT2AMAPTCYP1A2CYP2D6MEN1 | |
| SCHEMBL24766039 | 0.82 | MAPT (0.47) | KMT2AMAPTCYP1A2CYP2D6MEN1 | |
| SCHEMBL29434180 | 0.82 | GSK3B (0.47) | KMT2AMAPTCYP1A2CYP2D6MEN1 | |
| SCHEMBL17204101 | 0.81 | MAPT (0.61) | KMT2AMAPTCYP1A2CYP2D6MEN1 | |
| SCHEMBL24766029 | 0.79 | PTGS2 (0.47) | KMT2AMAPTCYP1A2CYP2D6MEN1 | |
| SCHEMBL29434163 | 0.79 | PTGS2 (0.47) | KMT2AMAPTCYP1A2CYP2D6MEN1 | |
| SCHEMBL23275363 | 0.79 | ADORA2A (0.59) | KMT2AMAPTCYP1A2CYP2D6MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11407737-B2 | Inhibitors of RAF kinases | KINNATE BIOPHARMA INC. (US) | 2022-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11407737-B2 | Inhibitors of RAF kinases | BRAF, RAF1, ARAF | KMT2A 1631/4885MAPT 2859/4885CYP1A2 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.